The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

Abstract

Since the introduction of positron emission tomography (PET) imaging with 68Ga-PSMA-HBED-CC (=68Ga-DKFZ-PSMA-11), this method has been regarded as a significant step forward in the diagnosis of recurrent prostate cancer (PCa). However, published data exist for small patient cohorts only. The aim of this evaluation was to analyse the diagnostic value of 68Ga… (More)
DOI: 10.1007/s00259-014-2949-6

Topics

Cite this paper

@inproceedings{AfsharOromieh2014TheDV, title={The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer}, author={Ali Afshar-Oromieh and Eleni Avtzi and Frederik L. Giesel and Tim Holland-Letz and Heinz G. Linhart and Matthias Eder and Michael Eisenhut and Silvan Boxler and Boris Hadaschik and Clemens Kratochwil and Wilko Weichert and Klaus Kopka and J{\"u}rgen Debus and Uwe Haberkorn}, booktitle={European Journal of Nuclear Medicine and Molecular Imaging}, year={2014} }